Navigation Links
AbbVie Named to S&P 500 Dividend Aristocrat Index
Date:1/21/2013

NORTH CHICAGO, Ill., Jan. 21, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, has been named to the S&P 500 Dividend Aristocrat Index for 2013.

The Dividend Aristocrat Index measures the performance of dividend-paying companies within the S&P 500 Index that have followed a policy of increasing dividends each year for at least 25 consecutive years.  In 2013, only 54 companies, approximately 11 percent of companies named to the S&P 500 Index, were included in this year's update. 

"AbbVie is honored to be included among the premier dividend-paying companies which are represented by this Index," said Bill Chase , executive vice president and chief financial officer, AbbVie. "AbbVie is committed to delivering attractive shareholder returns through a strong and sustainable dividend which we intend to grow in the future."

AbbVie was included as a result of the Index's change in its treatment of spin-off companies.  AbbVie was also named to the S&P High Yield Dividend Aristocrats Index, which measures the performance of companies within the S&P Composite 1500 that have followed a policy of increasing dividends each year for at least 20 consecutive years.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

 


'/>"/>
SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Roche Diagnostics Named to FORTUNE magazines 2013 list of "100 Best Companies to Work For"
2. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
3. Kareo Named a Top Workplace by the Orange County Register
4. Jack Cochran, MD, Executive Director of The Permanente Federation at Kaiser Permanente, named to National Quality Forum Board
5. MRI Interventions Named 2012 Global Company of the Year in Image-Guided Neural Interventions
6. MEI Pharmas Mitochondrial Inhibitor Drug Candidate ME-344 Named One of Top 10 Oncology Products for 2012
7. CardioMEMS Named as a Finalist for Intel Innovation Award
8. Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
9. West Virginia Rx Program Named a Mutual of America 2012 Community Partnership Award Winner
10. Vasomedical Named on Deloittes 2012 Technology Fast 500 List
11. Kimberly Ezdebski Named an ASQ-Certified Manager of Quality/Organizational Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
Breaking Medicine Technology:
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many ... event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids ... of all ages; it is a non-competitive, non-timed event, which is all about having ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):